Presented by the Solo and Small Firm Section of the Barristers Club
Opportunities for US Funds and Startups during COVID-19 & FIRRMA
||Thursday September 24, 2020
Founder, Kabealo PLLC
Partner, Haynes and Boone, LLP
Counsel, Haynes and Boone, LLP
FIRRMA expands CFIUS’s authority to review or even rewind minority foreign investments in “covered transactions” related to a U.S. company that involves specified “critical technology”, “critical infrastructure” or having access to “sensitive personal data” of U.S citizens. However, FIRRMA also specifically carves out a U.S. “Investment Fund” exception. With careful planning and well drafted fund documents, a qualifying U.S. fund is allowed to receive foreign funds and invest in “covered transactions” without subject to CIFUS review or mandatory reporting and in compliant with FIRRMA.
- What will make high-tech startups subject to CFIUS review under FIRRMA
- What is the advantage of US VC funds
- How can a US fund comply with FIRRMA
- CFIUS mandatory review process
Anna Liu, Steven Adair MacDonald & Partners & Liên Payne
For a printable flyer, click here.
Event Code: B200231
||BASF Law Student
Sign-in to your account and select Register Myself
at the bottom of the page. Use Forgot Username
or Forgot Password
if you don't know your account information. Don't have an account? Select Create Account
A link to access the Zoom meeting will be sent in your confirmation e-mail 2 hours prior to the start of the event.
To receive MCLE credit, you must sign in during the designated MCLE registration period. This activity is approved for Minimum Continuing Legal Education credit by the State Bar of California. BASF is a certified provider: Provider #103
People with disabilities should contact BASF regarding reasonable accommodations.